Anti-Oxidant Pathogenesis of High-Grade Glioma
Year: 2015
Type: article
Abstract: Current standard chemotherapy for HGG is temozolomide (TMZ) (Stupp et al., 2005).However, the efficacy of TMZ is only beneficial to half of patients because of TMZ resistance.Several recent reports suggest that suppression of ROS by antioxidant protein expression and STAT3 activation contributes to TMZ resistance (E. S.
Author: Ji Eun Song
Institution: The Ohio State University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2254772609
